The impact of biomolecular medicine and tissue engineering on plastic surgery in the 21st century

Plastic and Reconstructive Surgery

Volumn 105, Issue 7, 2000, Pages 2467-2481

  Lorenz, H Peter ^a   Hedrick, Marc H ^b   Chang, James ^b   Mehrara, Babak J ^b   Longaker, Michael T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOGLYCAN;

ARTICLE; CRANIOFACIAL SURGERY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TARGETING; GENOME; HAND SURGERY; PLASTIC SURGERY; PRIORITY JOURNAL; REGENERATION; TARGET CELL; WOUND HEALING;

EID: 0034033715     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200006000-00027     Document Type: Article

References (157)

1. Breuing, K., Andree, C., Helo, G., et al. Growth factors in the repair of partial thickness porcine skin wounds. Plast. Reconstr. Surg. 100: 657, 1997.
2. Deuel, T. F., Kawahara, R. S., Mustoe, T. A., and Pierce, A. F. Growth factors and wound healing: Platelet-derived growth factor as a model cytokine. Annu. Rev. Med. 42: 567, 1991.
3. Rappolee, D. A., Mark, D., Banda, M. J., and Werb, Z. Wound macrophages express TGF-alpha and other growth factors in vivo: Analysis by mRNA phenotyping. Science 241: 708, 1988.
4. O'Kane, S., and Ferguson, M. W. Transforming growth factor betas and wound healing. Int. J. Biochem. Cell Biol. 29: 63, 1997.
5. Frank, S., Madlener, M., and Werner, S. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271: 10188, 1996.
6. Brown, P. O., and Botstein, D. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21 (Suppl. 1): 33, 1999.
7. Iyer, V. R., Eisen, M. B., Ross, D. T., et al. The transcriptional program in the response of human fibroblasts to serum. Science 283: 83, 1999.
8. Mustoe, T. A., Pierce, G. F., Morishima, C., and Deuel, T. F. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J. Clin. Invest. 87: 694, 1991.
9. Cromack, D. T., Porras-Reyes, B., and Mustoe, T. A. Current concepts in wound healing: Growth factor and macrophage interaction. J. Trauma 30: S129, 1990.
10. Giannobile, W. V., Hernandez, R. A., Finkelman, R. D., et al. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J. Periodontal Res. 31: 301, 1996.
11. Cromack, D. T., Pierce, G. F., and Mustoe, T. A. TGF-beta and PDGF mediated tissue repair: Identifying mechanisms of action using impaired and normal models of wound healing. Prog. Clin. Biol. Res. 365: 359, 1991.
12. Suh, D. Y., Hunt, T. K., and Spencer, E. M. Insulin-like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology 131: 2399, 1992.
13. Tanaka, E., Ase, K., Okuda, T., et al. Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice. Biol. Pharm. Bull. 19: 1141, 1996.
14. Albertson, S., Hummel, R. P. D., Breeden, M., and Greenhalgh, D. G. PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice. Surgery 114: 368, 1993.
15. Gold, L. I., Sung, J. J., Siebert, J. W., and Longaker, M. T. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair. Am. J. Pathol. 150: 209, 1997.
16. Derynck, R., and Feng, X. H. TGF-beta receptor signaling. Biochim. Biophys. Acta 1333: F105, 1997.
17. Baker, J. C., and Harland, R. M. From receptor to nucleus: The Smad pathway. Curr. Opin. Genet. Dev. 7: 467, 1997.
18. Tredget, E. E., Nedelec, B., Scott, P. G., and Ghahary, A. Hypertrophic scars, keloids, and contractures: The cellular and molecular basis for therapy. Surg. Clin. North Am. 77: 701, 1997.
19. Bettinger, D. A., Yager, D. R., Diegelmann, R. F., and Cohen, I. K. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast. Reconstr. Surg. 98: 827, 1996.
20. Wassermann, R. J., Polo, M., Smith, P., et al. Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J. Surg. Res. 75: 74, 1998.
21. Sayah, D. N., Shaw, W. W., Holmes, E. C., et al. Down-regulation of apoptosis genes accounts for aberrant cellular growth in keloid tissue. Surg. Forum 49: 596, 1998.
22. Bitar, M. S., and Labbad, Z. N. Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J. Surg. Res. 61: 113, 1996.
23. Barone, E. J., Olutoye, O., Yager, D. R., et al. Interleukin-1a and collagenase levels in acute and chronic wounds. Surg. Forum 47: 351, 1996.
24. Bullen, E. C., Longaker, M. T., Updike, D. L., et al. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J. Invest. Dermatol. 104: 236, 1995.
25. Ferguson, M. W., Whitby, D. J., Shah, M., et al. Scar formation: The spectral nature of fetal and adult wound repair. Plast. Reconstr. Surg. 97: 854, 1996.
26. Adzick, N. S., and Lorenz, H. P. Cells, matrix, growth factors, and the surgeon: The biology of scarless fetal wound repair. Ann. Surg. 220: 10, 1994.
27. Lorenz, H. P., Lin, R. Y., Longaker, M. T., et al. The fetal fibroblast: The effector cell of scarless fetal skin repair. Plast. Reconstr. Surg. 96: 1251, 1995.
28. Lorenz, H. P., Longaker, M. T., Perkocha, L. A., et al. Scarless wound repair: A human fetal skin model. Development 114: 253, 1992.
29. Piscatelli, S. J., Michaels, B. M., Gregory, P., et al. Fetal fibroblast contraction of collagen matrices in vitro: The effects of epidermal growth factor and transforming growth factor-beta. Ann. Plast. Surg. 33: 38, 1994.
30. Loworn, H. N., III, Cheung, D. T., Nimni, M. E., et al. Relative distribution and crosslinking of collagen distinguish fetal from adult sheep wound repair. J. Pediatr. Surg. 34: 218, 1999.
31. Mori, Y., Hatamochi, A., Arakawa, M., and Ueki, H. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts. Arch. Dermatol. Res. 290: 158, 1998.
32. Ellis, I., Banyard, J., and Schor, S. L. Differential response of fetal and adult fibroblasts to cytokines: Cell migration and hyaluronan synthesis. Development 124: 1593, 1997.
33. Ellis, I. R., and Schor, S. L. Differential motogenic and biosynthetic response of fetal and adult skin fibroblasts to TGF-beta isoforms. Cytokine 10: 281, 1998.
34. Greenhalgh, D. G., Sprugel, K. H., Murray, M. J., and Ross, R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol. 136: 1235, 1990.
35. Slavin, J., Nash, J. R., and Kingsnorth, A. N. Effect of transforming growth factor beta and basic fibroblast growth factor on steroid-impaired healing intestinal wounds. Br. J. Surg. 79: 69, 1992.
36. Richard, J. L., Parer-Richard, C., Daures, J. P., et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot: A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 18: 64, 1995.
37. Jones, S. C., Curtsinger, L. J., Whalen, J. D., et al. Effect of topical recombinant TGF-beta on healing of partial thickness injuries. J. Surg. Res. 51: 344, 1991.
38. Steed, D. L. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers: Diabetic Ulcer Study Group. J. Vasc. Surg. 21: 71, 1995.
39. Mulliken, J. B., and Warman, M. Molecular genetics and craniofacial surgery. Plast. Reconstr. Surg. 97: 666, 1996.
40. Jabs, E. W. Toward understanding the pathogenesis of craniosynostosis through clinical and molecular correlates. Clin. Genet. 53: 79, 1998.
41. Robin, N. H. Molecular genetic advances in understanding craniosynostosis. Plast. Reconstr. Surg. 103: 1060, 1999.
42. Cohen, M. M., Jr. Transforming growth factor betas and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis. J. Bone Miner. Res. 12: 322, 1997.
43. Nuckolls, G. H., Shum, L., and Slavkin, H. Progress toward understanding craniofacial malformations. Cleft Palate Craniofac. J. 36: 12, 1999.
44. Brogi, E., Wu, T., Namiki, A., and Isner, J. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649, 1994.
45. Cohn, M. J., Izpisua-Belmonte, J. C., Abud, H., et al. Fibroblast growth factors induce additional limb development from the flank of chick embryos. Cell 80: 739, 1995.
46. Dealy, C. N., Clarke, K., and Scranto, V. Ability of FGFs to promote the outgrowth and proliferation of limb mesoderm is dependent on IGF-I activity. Dev. Dyn. 206: 463, 1996.
47. Eppley, B. L., Doucet, M., Connolly, D., and Feder, J. Enhancement of angiogenesis by bFGF in mandibular bone graft healing in the rabbit. J. Oral Maxillofac. Surg. 46: 391, 1988.
48. Globus, R. K., Patterson-Buckendahl, P., and Gospodarowicz, D. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor B. Endocrinology 123: 98, 1988.
49. Wilkie, A. O. M., Morriss-Kay, G. M., Jones, E. Y., and Heath, J. K. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5: 500, 1995.
50. Nuckolls, G., Shum, L., and Slavkin, H. Progress toward understanding craniofacial malformations. Cleft Palate Craniofac. J. 36: 12, 1999.
51. Bellus, G. A., Gaudenz, K., Zackai, E. H., et al. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat. Genet. 14: 174, 1996.
52. Muenke, M., Gripp, K. W., McDonald-McGinn, D. M., et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet. 60: 555, 1997.
53. el Ghouzzi, V., Le Merrer, M., Perrin-Schmitt, F., et al. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 15: 42, 1997.
54. Howard, T. D., Paznekas, W. A., Green, E. D., et al. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 15: 36, 1997.
55. Paznekas, W. A., Cunningham, M. L., Howard, T. D., et al. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am. J. Hum. Genet. 62: 1370, 1998.
56. Bradley, J. P., Levine, J. P., Blewett, C., et al. Studies in cranial suture biology: In vitro cranial suture fusion. Cleft Palate Craniofac. J. 33: 150, 1996.
57. Bradley, J. P., Levine, J. P., Roth, D. A., McCarthy, J. G., and Longaker, M. T. Studies in cranial suture biology: IV. Temporal sequence of posterior frontal cranial suture fusion in the mouse. Plast. Reconstr. Surg. 98: 1039, 1996.
58. Bradley, J. P., Levine, J., McCarthy, J., and Longaker, M. Studies in cranial suture biology: Regional dura mater determines in vitro cranial suture fusion. Plast. Reconstr. Surg. 100: 1091, 1997.
59. Bradley, J. P., Han, V. K., Roth, D. A., et al. Increased IGF-I and IGF-II mRNA and IGF-1 peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion. Plast. Reconstr. Surg. 104: 129, 1999.
60. Levine, J. P., Bradley, J. P., Roth, D. A., et al. Studies in cranial suture biology: Regional dura mater determines overlying suture biology. Plast. Reconstr. Surg. 101: 1441, 1998.
61. Mehrara, B. J., Mackool, R. J., McCarthy, J. G., et al. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast. Reconstr. Surg. 102: 1805, 1998.
62. Mehrara, B., Most, D., Chang, J., et al. Differential dural cytokine expression correlates with fetal cranial suture patency and calvarial bone formation. Surg. Forum 48: 710, 1998.
63. Mehrara, B. J., Steinbrech, D., Saadeh, P., et al. The expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann. Plast. Surg. 42: 509, 1999.
64. Mehrara, B. J., Greenwald, J., Chin, G., et al. Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures. Plast. Reconstr. Surg. 104: 1003, 1999.
65. Mehrara, B. J., Most, D., Chang, J., et al. Basic fibroblast growth factor and transforming growth factor beta-1 expression in the developing dura mater correlates with calvarial bone formation. Plast. Reconstr. Surg. 104: 435, 1999.
66. Most, D., Levine, J., Chang, J., et al. Studies in cranial suture biology: Up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast. Reconstr. Surg. 101: 1431, 1998.
67. Roth, D. A., Longaker, M. T., McCarthy, J. G., et al. Studies in cranial suture biology: Part I. Increased immunoreactivity for transforming growth factor-beta (b1, b2, b3) during rat cranial suture fusion. J. Bone Miner. Res. 12: 311, 1997.
68. Roth, D. A., Bradley, J. P., Levine, J. P., et al. Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion. Plast. Reconstr. Surg. 97: 693, 1996.
69. Roth, D. A., Gold, L. I., Han, V. K. M., et al. Immunolocalization of transforming growth factor B1, B2, and B3 and insulin-like growth factor I in premature cranial suture fusion. Plast. Reconstr. Surg. 99: 300, 1997.
70. Opperman, L. A., Sweeny, T. M., Redmon, J., et al. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev. Dyn. 198: 312, 1993.
71. Opperman, L. A., Persing, J., Sheen, R., and Ogle, R. In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseous obliteration. J. Craniofac. Surg. 5: 327, 1994.
72. Opperman, L. A., Passarelli, R. W., Morgan, E. P., et al. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J. Bone Miner. Res. 109: 1978, 1995.
73. Opperman, L., Passarelli, R., Nolen, A., et al. Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev. Biol. 32: 627, 1996.
74. Lin, K., Nolen, A., Gampper, T., et al. Elevated levels of transforming growth factors beta 2 and beta 3 in lambdoid sutures from children with persistent plagiocephaly. Cleft Palate Craniofac. J. 34: 331, 1997.
75. Opperman, L. A., Nolen, A. A., and Ogle, R. C. TGF-b1, TGF-b2, and TGF-b3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J. Bone Miner. Res. 12: 301, 1997.
76. Opperman, L. A., Chhabra, A., Nolen, A. A., et al. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production. J. Craniofac. Genet. Dev. Biol. 18: 150, 1998.
77. Mooney, M. P., Losken, H. W., Siegel, M. I., et al. Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis: Part I. Breeding demographics, inheritance pattern, and craniofacial anomalies. Cleft Palate Craniofac. J. 31: 1, 1994.
78. Burrows, A. M., Mooney, M. P., Smith, T. D., et al. Growth of the cranial vault in rabbits with congenital coronal suture synostosis. Cleft Palate Craniofac. J. 32: 235, 1995.
79. Mooney, M. P., Smith, T. D., Burrows, A. M., et al. Coronal suture pathology and synostotic progression in rabbits with congenital craniosynostosis. Cleft Palate Craniofac. J. 33: 369, 1996.
80. Smith, T. D., Mooney, M. P., Burrows, A. M., et al. Postnatal changes in the cranial base in rabbits with congenital coronal suture synostosis. J. Craniofac. Genet. Dev. Biol. 16: 107, 1996.
81. Mooney, M. P., Aston, C. E., Siegel, M. I., et al. Craniosynostosis with autosomal dominant transmission in New Zealand White rabbits. J. Craniofac. Genet. Dev. Biol. 16: 52, 1996.
82. Mooney, M. P., Losken, H. W., Tschakaloff, A., et al. Congenital bilateral coronal suture synostosis in a rabbit and craniofacial growth comparisons with experimental models. Cleft Palate Craniofac. J. 30: 121, 1993.
83. Singhal, V. K., Mooney, M. P., Burrows, A. M., et al. Age related changes in intracranial volume in rabbits with craniosynostosis. Plast. Reconstr. Surg. 100: 1121, 1997.
84. Chenevix-Trench, G., Jones, K., Green, A., et al. Cleft lip with or without cleft palate: Associations with transforming growth factor alpha and retinoic acid receptor loci. Am. J. Hum. Genet. 51: 1377, 1992.
85. Neel, J. A study of major congenital defects in Japanese infants. Am. J. Hum. Genet. 10: 398, 1958.
86. Chung, C., and Myrianthopoulos, N. Racial and prenatal factors in major congenital malformations. J. Hum. Genet. 20: 44, 1968.
87. Diehl, S. R., and Erickson, R. Genome scan for teratogen-induced clefting susceptibility loci in the mouse: Evidence of both allelic and locus heterogeneity distinguishing cleft lip and palate. Proc. Natl. Acad. Sci. U.S.A. 94: 5231, 1997.
88. Kelly, D., Goldberg, R., Wilson, D., et al. Confirmation that the velo-cardio-facial syndrome is associated with haploinsufficiency of genes at chromosome 22q11. Am. J. Med. Genet. 45: 308, 1993.
89. Morrow, B., Goldberg, R., Carlson, C., et al. Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am. J. Hum. Genet. 56: 1391, 1995.
90. Sander, A., Schmelzle, R., and Murray, J. Evidence for a microdeletion in 1q32-41 involving the gene responsible for Van der Woude syndrome. Hum. Mol. Genet. 3: 575, 1994.
91. Baldwin, C. T., Lipsky, N., Hoth, C., et al. Mutations in PAX3 associated with Waardenburg syndrome type I. Hum. Mutat. 3: 205, 1994.
92. Tassabehji, M., Newton, V., and Read, A. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet. 8: 251, 1994.
93. Hecht, J., Yang, P., Michels, V., and Buetow, K. Complex segregation analysis of nonsyndromic cleft lip and palate. Am. J. Hum. Genet. 49: 674, 1991.
94. Hecht, J., Yang, P., Michels, V., and Buetow, K. Cleft lip and palate: No evidence of linkage to transforming growth factor alpha. Am. J. Hum. Genet. 49: 682, 1991.
95. Hecht, J., Wang, Y., Connor, B., et al. Nonsyndromic cleft lip and palate: No evidence of linkage to HLA or factor 13A. Am. J. Hum. Genet. 52: 1230, 1993.
96. Carinci, F., Pezzetti, F., Scapoli, L., et al. Nonsyndromic cleft lip and palate: Evidence of linkage to a microsatelite marker on 6p23. Am. J. Med. Genet. 56: 337, 1995.
97. Shiang, R., Lidral, A., Ardinger, H., et al. Association of transforming growth factor alpha gene polymorphisms with nonsyndromic cleft palate only (CPO). Am. J. Hum. Genet. 53: 836, 1993.
98. Stein, J., Mulliken, J., Stal, S., et al. Nonsyndromic cleft lip with or without cleft palate: Evidence of linkage to BCL3 in 17 multigenerational families. Am. J. Hum. Genet. 57: 257, 1995.
99. Wyszynski, D. F., Maestri, N., McIntosh, I., et al. Evidence for an association between markers on chromosome 19q and non-syndromic cleft lip with or without cleft palate in two groups of multiplex families. Hum. Genet. 99: 22, 1997.
100. Miettinen, P., Chin, J., Shum, L., et al. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat. Genet. 22: 69, 1999.
101. De Felice, M., Ovitt, C., Biffali, E., et al. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat. Genet. 19: 395, 1999.
102. Satokata, I., and Maas, R. Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat. Genet. 6: 348, 1994.
103. Culiat, C. T., Stubbs, L., Woychick, R., et al. Deficiency of the beta 3 subunit of the type A gamma-aminobutyric acid receptor causes cleft palate in mice. Nat. Genet. 11: 344, 1995.
104. Kaartinen, V., Voncken, J. W., Shuler, C., et al. Abnormal lung development and cleft palate in mice lacking TGF-B3 indicates defects in epithelial-mesenchymal interactions. Nat. Genet. 11: 415, 1995.
105. Clifton-Bligh, R. J., Wentworth, J. M., Heinz, P., et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate, choanal atresia. Nat. Genet. 19: 399, 1998.
106. Jaskoll, T., Choy, H., Chen, H., and Melnick, M. Developmental expression and CORT-regulation of TGF-beta and EGF receptor mRNA during mouse palatal morphogenesis: Correlation between CORT-induced cleft palate and TGF-beta 2 mRNA expression. Teratology 54: 34, 1996.
107. Bell, W. H., Harper, R. P., Gonzalez, M., et al. Distraction osteogenesis to widen the mandible. Br. J. Oral Maxillofac. Surg. 35: 11, 1997.
108. Cohen, S. R., Rutrick, R. E., and Burstein, F. D. Distraction osteogenesis of the human craniofacial skeleton: Initial experience with new distraction system. J. Craniofac. Surg. 6: 368, 1995.
109. Costantino, P. D., Shybut, G., Friedman, C. D., et al. Segmental mandibular regeneration by distraction osteogenesis. Arch. Otolaryngol. Head Neck Surg. 116: 535, 1990.
110. Guerrero, C. A., Bell, W. H., Contasti, G. I., and Rodriguez, A. M. Mandibular widening by intraoral distraction osteogenesis. Br. J. Oral Maxillofac. Surg. 35: 383, 1997.
111. McCarthy, J. G., Schreiber, J., Karp, N., et al. Lengthening of the human mandible by gradual distraction. Plast. Reconstr. Surg. 89: 1, 1992.
112. McCarthy, J. G., and Turk, A. E. Distraction osteogenesis of the craniofacial skeleton: Mandibular reconstruction. Adv. Plast. Reconstr. Surg. 12: 31, 1996.
113. Sawaki, Y., Ohkubo, H., Hibi, H., and Ueda, M. Mandibular lengthening by distraction osteogenesis using osseointegrated implants and an intraoral device: A preliminary report. J. Oral Maxillofac. Surg. 54: 594, 1996.
114. Barone, C. M., Ferder, M., Jimenez, D. F., et al. Distraction of the frontal bone outside the cranial plane: A rabbit model. J. Craniofac. Surg. 4: 177, 1993.
115. Carls, F. R., Jackson, I. T., and Topf, J. S. Distraction osteogenesis for lengthening of the hard palate: Part I. A possible new treatment concept for velopharyngeal incompetence. Experimental study in dogs. Plast. Reconstr. Surg. 100: 1635, 1997.
116. Carls, F. R., Schupbach, P., Sailer, H. F., and Jackson, I. T. Distraction osteogenesis for lengthening of the hard palate: Part II. Histological study of the hard and soft palate after distraction. Plast. Reconstr. Surg. 100: 1648, 1997.
117. Chin, M., and Toth, B. A. Le Fort III advancement with gradual distraction using internal devices. Plast. Reconstr. Surg. 100: 819, 1997.
118. Cohen, S. R., Burstein, F. D., Stewart, M. B., and Rathburn, M. A. Maxillary-midface distraction in children with cleft lip and palate: A preliminary report. Plast. Reconstr. Surg. 99: 1421, 1997.
119. Glat, P. M., Staffenberg, D. A., Karp, N. S., et al. Multidimensional distraction osteogenesis: The canine zygoma. Plast. Reconstr. Surg. 94: 753, 1994.
120. Lalikos, J. F., Tschakaloff, A., Mooney, M. P., et al. Internal calvarial bone distraction in rabbits with experimental coronal suture immobilization: Effects of overdistraction. Plast. Reconstr. Surg. 96: 689, 1995.
121. Molina, F., Ortiz Monasterio, F., de la Paz Aguilar, M., and Barrera, J. Maxillary distraction: Aesthetic and functional benefits in cleft lip-palate and prognathic patients during mixed dentition. Plast. Reconstr. Surg. 101: 951, 1998.
122. Ortiz Monasterio, F., Molina, F., Andrade, L., et al. Simultaneous mandibular and maxillary distraction in hemifacial microsomia in adults: Avoiding occlusal disasters. Plast. Reconstr. Surg. 100: 852, 1997.
123. Pittman, T., Rinehart, G. C., Hagen, R., and Saldana, E. Cranial vault moulding by the transcutaneous activation of implanted magnets. Pediatr. Neurosurg. 27: 78, 1997.
124. Polley, J. W., Figueroa, A. A., Charbel, F. T., et al. Monobloc craniomaxillofacial distraction osteogenesis in a newborn with severe craniofacial synostosis: A preliminary report. J. Craniofac. Surg. 6: 421, 1995.
125. Polley, J. W., and Figueroa, A. A. Management of severe maxillary deficiency in childhood and adolescence through distraction osteogenesis with an external, adjustable, rigid distraction device. J. Craniofac. Surg. 8: 181, 1997.
126. Rachmiel, A., Jackson, I. T., Potparic, A., and Laufer, D. Midface advancement in sheep by gradual distraction: A 1-year follow-up study. J. Oral Maxillofac. Surg. 53: 525, 1995.
127. Staffenberg, D. A., Wood, R. J., McCarthy, J. G., et al. Midface distraction advancements in the canine without osteotomies. Ann. Plast. Surg. 34: 512, 1995.
128. McCarthy, J. G., Williams, J. K., Grayson, B. H., and Crombie, J. S. Controlled multiplanar distraction of the mandible: Device development and clinical application. J. Craniofac. Surg. 9: 322, 1998.
129. Williams, J. K., McCarthy, J. G., Grayson, B. H., et al. Controlled multiplanar distraction of the mandible: Part II. Laboratory studies of sagittal (anteroposterior) and vertical (superoinferior) movements. J. Craniofac. Surg. 9: 504, 1998.
130. Sawaki, Y., Ohkubo, H., Hibi, H., and Ueda, M. Mandibular lengthening by distraction osteogenesis using osseointegrated implants and an intraoral device: A preliminary report. J. Oral Maxillofac. Surg. 54: 594, 1996.
131. Guerrero, C. A., Bell, W. H., Contasti, G. I., and Rodriguez, A. M. Mandibular widening by intraoral distraction osteogenesis. Br. J. Oral Maxillofac. Surg. 35: 383, 1997.
132. Rowe, N. M., Mehrara, B. J., Dudziak, M. E., et al. Rat mandibular distraction osteogenesis: Part I. Histologic and radiographic analysis. Plast. Reconstr. Surg. 102: 2022, 1998.
133. Mehrara, B. J., and Longaker, M. T. New developments in craniofacial surgery research. Cleft Palate Craniofac. J. 36: 377, 1999.
134. Mehrara, B. J., Rowe, N. M., Steinbrech, D. S., et al. Rat mandibular distraction osteogenesis: Part II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression. Plast. Reconstr. Surg. 103: 536, 1999.
135. Kleinert, H. E., Spokevicius, S., and Papas, N. H. History of flexor tendon repair. J. Hand Surg. (Am.) 20: S46, 1995.
136. Lister, G. D., Kleinert, H. E., Kutz, J. E., and Atasoy, E. Primary flexor tendon repair followed by immediate controlled mobilization. J. Hand Surg. (Am.) 2: 441, 1977.
137. Banes, A. J., Donlon, K., Link, G. W., et al. Cell populations of tendon: A simplified method for isolation of synovial cells and internal fibroblasts: Confirmation of origin and biologic properties. J. Orthop. Res. 6: 83, 1988.
138. Russell, J. E., and Manske, P. R. Ascorbic acid requirement for optimal flexor tendon repair in vitro. J. Orthop. Res. 9: 714, 1991.
139. Lou, J., Kubota, H., Hotokezaka, S., et al. In vivo gene transfer and overexpression of focal adhesion kinase (pp125 FAK) mediated by recombinant adenovirus-induced tendon adhesion formation and epitenon cell change. J. Orthop. Res. 15: 911, 1997.
140. Border, W. A., and Noble, N. A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331: 1286, 1994.
141. Chang, J., Siebert, J. W., Schendel, S. A., et al. Scarless wound healing: Implications for the aesthetic surgeon. Aesthetic Plast. Surg. 19: 237, 1995.
142. Chang, J., Most, D., Stelnicki, E., et al. Gene expression of transforming growth factor beta-1 in rabbit zone II flexor tendon wound healing: Evidence for dual mechanisms of repair. Plast. Reconstr. Surg. 100: 937, 1997.
143. Chang, J., Most, D., Thunder, R., et al. Molecular studies in flexor tendon wound healing: The role of basic fibroblast growth factor gene expression. J. Hand Surg. (Am.) 23: 1052, 1998.
144. Chang, J., Thunder, R., Most, D., et al. Studies in flexor tendon wound healing: Neutralizing antibody to TGF-beta 1 increases postoperative range of motion. Plast. Reconstr. Surg. 105: 148, 2000.
145. Merle, M., Foucher, G., and Engloff, D. V. Peritendinous and perineural scar and adhesions: Treatment with a new anti-adhesion barrier gel, ADCON-T/N. Hand Surg. P. 33, 1997.
146. Merle, M., Dautel, G., and DeMedinaceli, L. Inhibition of Peritendinous Adhesions by ADCON-T/N in a Rabbit Flexor Tendon Model. Presented at the 6th Congress of the International Federation of Societies for Surgery of the Hand. Helsinki, Finland, 1995.
147. Watchmaker, G. P., and Mackinnon, S. E. Advances in peripheral nerve repair. Clin. Plast. Surg. 24: 63, 1997.
148. Berger, A., and Lassner, F. Peripheral nerve allografts: Survey of present state in an experimental model of the rat. Microsurgery 15: 773, 1994.
149. Buttemeyer, R., Rao, U., and Jones, N. F. Peripheral nerve allograft transplantation with FK506: Functional, histological, and immunological results before and after discontinuation of immunosuppression. Ann. Plast. Surg. 35: 396, 1995.
150. Mackinnon, S. E., and Hudson, A. R. Clinical application of peripheral nerve transplantation. Plast. Reconstr. Surg. 90: 695, 1992.
151. Lindsay, R. M., Wiegand, S. J., Altar, C. A., and DiStefano, P. S. Neurotrophic factors: From molecule to man. Trends Neurosci. 17: 182, 1994.
152. Nath, R. K., Kwon, B., Mackinnon, S. E., et al. Antibody to transforming growth factor beta reduces collagen production in injured peripheral nerve. Plast. Reconstr. Surg. 102: 1100, 1998.
153. Karanas, Y., Hu, M., Bogdan, M., et al. Gene expression of TGF-beta isoforms in interposition nerve grafting. Surg. Forum. 50: 548, 1999.
154. Ferber, D. Lab-grown organs begin to take shape. Science 284: 422, 1999.
155. Solter, D., and Gearhart, J. Enhanced: Putting stem cells to work. Science 283: 1468, 1999.
156. Pennisi, E. Cloning: The lamb that roared. Science 278: 2038, 1997.
157. Ferber, D. From the lab to the clinic. Science 284: 423, 1999.